The online version of this article (doi:10.1186/1477-7819-10-224) contains supplementary material, which is available to authorized users.
All authors declare no competing interests.
HKL conceived and designed the study; HKL, MSC and THK acquired the data; HKL and MSC analyzed and interpreted the data; HKL prepared for the manuscript. HKL and THK edited the manuscript. All authors read and approved the final manuscript.
Mucins are high molecular glycoproteins and play protective and lubricating roles in various epithelial tissues. Deregulated expression of mucins is involved in carcinogenesis and tumor invasion. MUC4 expression has been identified as a poor prognostic factor in pancreatobiliary carcinomas. To date, the relation between MUC4 expression and prognosis in gallbladder carcinoma remains to be determined. Authors examined MUC4 expression in gallbladder carcinoma and investigated its impact on prognosis.
The expression profiles of MUC4, MUC1, MUC2 mucins in gallbladder carcinoma tissues from 63 patients were investigated using immunohistochemical staining.
For gallbladder carcinoma, positive staining of MUC4, MUC1, and MUC2 was 55.6%, 81.0%, 28.6%, respectively. There was a significant correlation between the expression of MUC4 and the expression of MUC1 or MUC2 (p = 0.004, p = 0.009, respectively). Univariate analysis showed that MUC4 expression (p = 0.047), differentiation (p < 0.05), T-stage (p < 0.05) and lymph node metastasis (p < 0.001) were significantly associated with poor survival. Expression of MUC1 and MUC2 was not correlated to survival. The backward stepwise multivariate analysis showed that MUC4 expression (p = 0.039) and lymph node metastasis (p = 0.001) were significant independent risk factors. In combined assessment of MUC4 and MUC2 expression, MUC4 positive and MUC2 negative group showed a significantly worse outcome than MUC4 negative groups(MUC4-/MUC2+ and MUC4-/MUC2-) and MUC4/MUC2 co-expression group(MUC4+/MUC2+) (p < 0.05).
MUC4 expression in gallbladder carcinoma is an independent poor prognostic factor. Therefore, MUC4 expression may be a useful marker to predict the outcome of patients with surgically resected gallbladder carcinoma. MUC2 expression may have prognostic value when combined with MUC4 expression.
Authors’ original file for figure 112957_2012_1109_MOESM1_ESM.pdf
Authors’ original file for figure 212957_2012_1109_MOESM2_ESM.pdf
Authors’ original file for figure 312957_2012_1109_MOESM3_ESM.pdf
Authors’ original file for figure 412957_2012_1109_MOESM4_ESM.pdf
Authors’ original file for figure 512957_2012_1109_MOESM5_ESM.pptx
Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, Niehans GA: Mucin gene expression in normal, preneoplastic and neoplastic human gastric epithelium. Cancer Res. 1995, 55: 2681-2690. PubMed
Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS: Heterogenicity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 1993, 53: 641-651. PubMed
Porchet N, Nguyen VC, Dufosse J, Audie JP, Guyonnet-Duperat V, Gross MS, Denis C, Degand P, Bernheim A, Aubert JP: Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun. 1991, 175: 414-422. 10.1016/0006-291X(91)91580-6. CrossRefPubMed
Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T, Osako M, Takao S, Batra SK, Aikou T, Imai K, Yonezawa S: MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol. 2005, 58: 845-852. 10.1136/jcp.2004.023572. PubMedCentralCrossRefPubMed
Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M: American joint committee on cancer: cancer staging manual. 2002, Chicago: Springer, 6 CrossRef
Miyahara N, Shoda J, Ishige K, Kawamoto T, Ueda T, Taki R, Ohkohchi N, Hyodo I, Thomas MB, Krishnamurthy S, Carraway KL, Irimura T: MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications. Eur J Cancer. 2008, 44: 1048-1056. 10.1016/j.ejca.2008.03.007. CrossRefPubMed
Yamato T, Sasaki M, Watanabe Y, Nakanuma Y: Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study. J Pathol. 1999, 188: 30-37. 10.1002/(SICI)1096-9896(199905)188:1<30::AID-PATH291>3.0.CO;2-Q. CrossRefPubMed
Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, Makuuchi H: MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Oncol Rep. 2001, 8: 485-489. PubMed
Horinouchi M, Nagata K, Nakamura A, Goto M, Takao S, Sakamoto M, Fukushima N, Miwa A, Irimura T, Imai K, Sato E, Yonezawa : Expression of different glycoforms of membrane mucin(MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem Cytochem. 2003, 36: 443-453. 10.1267/ahc.36.443. CrossRef
- Prognostic significance of muc4 expression in gallbladder carcinoma
Hyeon Kook Lee
Tae Hun Kim
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II